Pennsylvania medical cannabis patients reported improved quality of life within 30 days | Research

The takeaway

Among 103 Pennsylvania medical cannabis patients followed for 90 days, significant improvements in physical functioning, emotional well-being, and pain were observed within the first month and sustained throughout the study.

Medical cannabis prescribers, state program administrators, and patients considering medical cannabis

103 patients showed improvements within 30 days

What the researchers found

Participants showed significant improvements in physical and social functioning, emotional well-being, and energy within 30 days that persisted through 90 days. Those using inhaled or vaped products showed greater emotional well-being improvement than flower users. Patients using cannabis for opioid use consumed significantly more THC than those treating anxiety, chronic pain, or IBD.

Why it matters

Real-world data from state medical cannabis programs can help bridge the evidence gap between clinical trials and how patients actually experience medical cannabis in practice.

The numbers in context

103 completers over 90 days; significant improvements in physical functioning, social functioning, emotional well-being, and energy within first 30 days; significant decreases in emotional limitations, fatigue, and pain; vapers showed higher emotional well-being gains than flower users

How the study worked

Prospective observational study of 103 Pennsylvania Medical Marijuana Program patients surveyed electronically every 30 days over 90 days about use patterns and quality of life changes.

What this study cannot tell us

No control group; self-selected patients likely positive toward cannabis; short 90-day follow-up; self-reported outcomes without clinical verification; no blinding; potential placebo effect

How to read the evidence

Uncontrolled prospective survey of self-selected medical cannabis patients without blinding or clinical verification of outcomes.

When this study was published

2024 study with 90-day follow-up

The bigger picture

As more states implement medical cannabis programs, understanding patient-reported outcomes across different conditions and consumption methods helps inform both clinical practice and policy.

Questions still open

Do these quality of life improvements persist beyond 90 days? Why did vape/inhaled users show greater emotional well-being improvement than flower users? What accounts for the higher THC consumption among those treating opioid use?

Common questions

How quickly did patients see benefits from medical cannabis?

Significant improvements in physical and social functioning, emotional well-being, energy, and pain were observed within the first 30 days of the study. These improvements held steady through the full 90-day follow-up period.

Did the method of consumption matter?

Participants who used inhaled or vaped products (cartridges and concentrates) showed significantly greater improvements in emotional well-being compared to those who used flower. Vape users also tended to be younger.

Read the original research

Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients.

Medical cannabis and cannabinoids, 7(1), 44-50

View on PubMed ↗Publisher’s paper ↗

Citation

Kelley, Mark D; Obaid, Marwah; Miller, Edward M; Bowie, Marla; Heeter, Zachary S. (2024). Observational Analysis of the Influence of Medical Marijuana Use on Quality of Life in Patients.. Medical cannabis and cannabinoids, 7(1), 44-50. https://doi.org/10.1159/000536591